TRUE Private Wealth Advisors’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-470
Closed -$21K 266
2020
Q4
$21K Hold
470
﹤0.01% 439
2020
Q3
$15K Sell
470
-5
-1% -$160 ﹤0.01% 440
2020
Q2
$13K Sell
475
-21
-4% -$608 ﹤0.01% 449
2020
Q1
$13K Sell
496
-1
-0.2% -$30 ﹤0.01% 410
2019
Q4
$16K Buy
+497
New +$18K ﹤0.01% 518
2019
Q3
Sell
-496
Closed -$21K 247
2019
Q2
$21K Buy
+496
New +$21.2K ﹤0.01% 453
2018
Q4
Sell
-592
Closed -$40.6K 283
2018
Q3
$40.6K Buy
+592
New +$38.1K 0.01% 488

Other funds holding AVNS

TRUE Private Wealth Advisors's AVNS Position: Q1 2021 in Review

TRUE Private Wealth Advisors sold out of Avanos Medical (AVNS) in Q1 2021, closing a stake of 470 shares — an estimated $21K sold.

TRUE Private Wealth Advisors first reported a position in AVNS in Q3 2018 and held it in 7 quarters. The position peaked at $40.6K in Q3 2018. 291 funds tracked by Wall St. Rank hold AVNS as of Q1 2021.

  • TRUE Private Wealth Advisors reported no remaining Avanos Medical position as of Q1 2021 after selling out during the quarter.
  • TRUE Private Wealth Advisors sold 470 Avanos Medical shares in Q1 2021, an estimated $21K.
  • TRUE Private Wealth Advisors first reported a position in Avanos Medical in Q3 2018 and held it in 7 quarters.
  • TRUE Private Wealth Advisors's Avanos Medical position peaked at $40.6K in Q3 2018.
  • 291 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2021.

Based on TRUE Private Wealth Advisors's 13F filing for Q1 2021, filed 12 May 2021.